CDH5
Basic information
Region (hg38): 16:66366690-66404784
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDH5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 60 | 66 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 60 | 6 | 1 |
Variants in CDH5
This is a list of pathogenic ClinVar variants found in the CDH5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-66379362-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
16-66379374-G-A | not specified | Likely benign (Jul 19, 2023) | ||
16-66379374-G-T | not specified | Uncertain significance (Jul 21, 2021) | ||
16-66379389-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
16-66379398-G-A | not specified | Uncertain significance (May 30, 2023) | ||
16-66379435-G-A | not specified | Uncertain significance (Dec 13, 2021) | ||
16-66379464-C-G | not specified | Uncertain significance (Nov 30, 2021) | ||
16-66379468-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
16-66379539-G-A | not specified | Uncertain significance (Nov 07, 2022) | ||
16-66386827-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
16-66386863-G-A | Marfanoid habitus and intellectual disability | Uncertain significance (-) | ||
16-66386872-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
16-66386949-C-A | not specified | Uncertain significance (May 06, 2024) | ||
16-66386983-G-C | not specified | Uncertain significance (Oct 22, 2021) | ||
16-66387038-A-T | not specified | Uncertain significance (Dec 13, 2023) | ||
16-66387056-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
16-66388425-G-T | not specified | Uncertain significance (Jun 06, 2023) | ||
16-66389361-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
16-66389366-A-G | not specified | Likely benign (Jun 06, 2023) | ||
16-66389376-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
16-66389417-G-C | not specified | Uncertain significance (Jul 30, 2023) | ||
16-66389447-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
16-66389471-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
16-66390419-C-T | Benign (Aug 20, 2018) | |||
16-66390420-G-A | not specified | Uncertain significance (Dec 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDH5 | protein_coding | protein_coding | ENST00000341529 | 11 | 38154 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.513 | 0.487 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.518 | 479 | 512 | 0.936 | 0.0000344 | 5138 |
Missense in Polyphen | 155 | 184.65 | 0.8394 | 1984 | ||
Synonymous | -0.515 | 240 | 230 | 1.04 | 0.0000184 | 1567 |
Loss of Function | 4.15 | 7 | 32.6 | 0.215 | 0.00000184 | 345 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000129 | 0.000123 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. This cadherin may play a important role in endothelial cell biology through control of the cohesion and organization of the intercellular junctions. It associates with alpha-catenin forming a link to the cytoskeleton. Acts in concert with KRIT1 to establish and maintain correct endothelial cell polarity and vascular lumen. These effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for activation of PRKCZ and for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction. {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:21269602}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);VEGFA-VEGFR2 Signaling Pathway;Signal Transduction;VEGFA-VEGFR2 Pathway;Signaling by VEGF;Cell-cell junction organization;Adherens junctions interactions;Cell junction organization;Signaling by Receptor Tyrosine Kinases;Cell-Cell communication;Signaling events mediated by VEGFR1 and VEGFR2;S1P2 pathway;VEGFR2 mediated vascular permeability
(Consensus)
Recessive Scores
- pRec
- 0.222
Intolerance Scores
- loftool
- 0.498
- rvis_EVS
- -1.06
- rvis_percentile_EVS
- 7.58
Haploinsufficiency Scores
- pHI
- 0.503
- hipred
- Y
- hipred_score
- 0.670
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.713
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdh5
- Phenotype
- reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; liver/biliary system phenotype; immune system phenotype; vision/eye phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- cdh5
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- cell morphogenesis;blood vessel maturation;cell-cell junction assembly;homophilic cell adhesion via plasma membrane adhesion molecules;transforming growth factor beta receptor signaling pathway;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;cell-cell adhesion mediated by cadherin;positive regulation of angiogenesis;negative regulation of inflammatory response;cell-cell adhesion;positive regulation of establishment of endothelial barrier;regulation of establishment of cell polarity
- Cellular component
- plasma membrane;cell-cell junction;cell-cell adherens junction;bicellular tight junction;cell surface;membrane;integral component of membrane;catenin complex;cell junction
- Molecular function
- signaling receptor binding;calcium ion binding;protein binding;beta-catenin binding;cytoskeletal protein binding;protein homodimerization activity;ion channel binding;cadherin binding